Skip to main content
Erschienen in: World Journal of Urology 5/2004

01.10.2004 | Topic Paper

Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions

verfasst von: Tillmann Loch, Ursula Eppelmann, Jan Lehmann, Bernd Wullich, Annemie Loch, Michael Stöckle

Erschienen in: World Journal of Urology | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

Transrectal ultrasound (TRUS) guided multiple systematic random biopsies are presently the method of choice for determining the presence or absence of prostate cancer. TRUS image information is only used to guide the biopsy needle into the prostate, but not to localize and target cancerous lesions. Our aim in this study was to evaluated the possible predictive value of tumor suspicious endosonographic lesions of the prostate for prostate biopsies. We prospectively compared six systematic biopsies with lesion guided biopsies in a consecutive series of 217 patients. All patients had a prostate specific antigen (PSA) level of >4 ng/ml without a history of prostate disease. In a subgroup of 145 men with sonomorphologic lesions suggestive for prostate cancer (hypoechoic areas or asymmetries predominantly in the peripheral zone), lesion-guided biopsies were taken in addition to the systematic biopsies. We evaluated the number of tumors which were diagnosed or missed by both of the biopsy strategies. Of the 217 evaluated patients, 64 (29%) had histology confirmed cancer. Four patients with negative sextant biopsies had a positive TRUS guided biopsy. Out of 145 patients with a normal TRUS, three were cancer positive by sextant biopsy. A total of 1,387 individual biopsy cores were evaluated. Of the 1,304 systematic biopsy cores, 182 (14%) were positive and 1,122 (86%) negative. Of the 329 TRUS lesion guided biopsy cores 139 (42%) were positive and 190 (58%) negative. Patients with tumor suggestive TRUS lesions have a considerably higher risk of being diagnosed with prostate cancer compared to patients without such lesions. Both systematic sextant and TRUS lesion guided biopsies missed detectable prostate cancer in a minority of patients. Taking the endosonographic morphology of the prostate gland into consideration for biopsy strategies may improve the quality of the biopsy and avoid unnecessary invasive procedures in selected cases.
Literatur
1.
Zurück zum Zitat Potosky AL, Miller BA, Albertson PC, Kramer BS (1995) The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548–552CrossRefPubMed Potosky AL, Miller BA, Albertson PC, Kramer BS (1995) The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548–552CrossRefPubMed
2.
Zurück zum Zitat Shinohara K, Scardino PT, Carter SC, Wheeler TM (1989) Pathologic basis of the sonographic appearance of the normal and malignant prostate. Urol Clin Am 16:675–678 Shinohara K, Scardino PT, Carter SC, Wheeler TM (1989) Pathologic basis of the sonographic appearance of the normal and malignant prostate. Urol Clin Am 16:675–678
3.
Zurück zum Zitat Lee F, Gray JM, McLeary RD, Meadows TK, Kumasaka GH, Borlaza GS, Straub WH, Lee FJr, Solomon MH, McHugh TA et al. (1985) Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology, and staging. Prostate 7:117–129PubMed Lee F, Gray JM, McLeary RD, Meadows TK, Kumasaka GH, Borlaza GS, Straub WH, Lee FJr, Solomon MH, McHugh TA et al. (1985) Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology, and staging. Prostate 7:117–129PubMed
4.
Zurück zum Zitat Ellis WJ, Brawer MK (1994) The significance of isoechoic prostatic carcinoma. J Urol 152:2304–2307PubMed Ellis WJ, Brawer MK (1994) The significance of isoechoic prostatic carcinoma. J Urol 152:2304–2307PubMed
5.
Zurück zum Zitat Mettlin C, Murphy GP, Babaian RJ, Chesley A, Kane RA, Littrup PJ, Mostofi FK, Ray PS, Shanberg AM, Toi A (1996) The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer 77:150–159CrossRefPubMed Mettlin C, Murphy GP, Babaian RJ, Chesley A, Kane RA, Littrup PJ, Mostofi FK, Ray PS, Shanberg AM, Toi A (1996) The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer 77:150–159CrossRefPubMed
6.
Zurück zum Zitat Nava L, Montorsi F, Consonni P, Scattoni V, Guazzoni G, Rigatti PJ (1997) Results of a prospective randomized study comparing 6, 12 and 18 transrectal ultrasound guided sextant biopsies in patients with elevated PSA, normal DRE, and normal prostatic ultrasound. Urology 157:59 Nava L, Montorsi F, Consonni P, Scattoni V, Guazzoni G, Rigatti PJ (1997) Results of a prospective randomized study comparing 6, 12 and 18 transrectal ultrasound guided sextant biopsies in patients with elevated PSA, normal DRE, and normal prostatic ultrasound. Urology 157:59
7.
Zurück zum Zitat Vashi AR, Wojno KJ, Gillespie B, Oesterling JE (1997) Patient age and prostate gland size determine the appropriate number of cores per prostate biopsy. J Urol 157:365 Vashi AR, Wojno KJ, Gillespie B, Oesterling JE (1997) Patient age and prostate gland size determine the appropriate number of cores per prostate biopsy. J Urol 157:365
8.
Zurück zum Zitat Jones JS, Oder M, Zippe CD (2002) Saturation biopsy with periprostatic block can be performed in office. J Urol 168:2108–2110CrossRefPubMed Jones JS, Oder M, Zippe CD (2002) Saturation biopsy with periprostatic block can be performed in office. J Urol 168:2108–2110CrossRefPubMed
9.
Zurück zum Zitat Fleshner N, Klotz L (2002) Role of “saturation biopsy” in the detection of prostate cancer among difficult diagnostic cases. Urology 60:93–97CrossRefPubMed Fleshner N, Klotz L (2002) Role of “saturation biopsy” in the detection of prostate cancer among difficult diagnostic cases. Urology 60:93–97CrossRefPubMed
10.
Zurück zum Zitat Chrouser KL, Lieber MM (2004) Extended and saturation needle biopsy for the diagnosis of prostate cancer. Curr Urol Rep 5:226–230PubMed Chrouser KL, Lieber MM (2004) Extended and saturation needle biopsy for the diagnosis of prostate cancer. Curr Urol Rep 5:226–230PubMed
11.
Zurück zum Zitat Loch T, Gettys T, Cochran JS, Fulgham PF, Bertermann H (1990) Computer-aided image-analysis in transrectal ultrasound of the prostate. World J Urol 8:150–153 Loch T, Gettys T, Cochran JS, Fulgham PF, Bertermann H (1990) Computer-aided image-analysis in transrectal ultrasound of the prostate. World J Urol 8:150–153
12.
Zurück zum Zitat Holm HH, Gammelgaard J (1981) Ultrasonocally guided precise needle placement in the prostate and the seminal vesicles. J Urol 142:66–70 Holm HH, Gammelgaard J (1981) Ultrasonocally guided precise needle placement in the prostate and the seminal vesicles. J Urol 142:66–70
13.
Zurück zum Zitat Lee F, McLeary RD, Meadows TR (1985) Transrectal ultrasound in the diagnosis of prostatic cancer: location, echogenicity, histopathology and staging. Prostate 7:117–129PubMed Lee F, McLeary RD, Meadows TR (1985) Transrectal ultrasound in the diagnosis of prostatic cancer: location, echogenicity, histopathology and staging. Prostate 7:117–129PubMed
14.
Zurück zum Zitat Loch T, McNeal JE, Stamey TA (1995) Interpretation of bilateral positive biopsies in prostate cancer. J Urol 154:1078–1083CrossRefPubMed Loch T, McNeal JE, Stamey TA (1995) Interpretation of bilateral positive biopsies in prostate cancer. J Urol 154:1078–1083CrossRefPubMed
15.
Zurück zum Zitat Terris MK, Freiha FS, McNeal JE, Stamey TA (1991) Efficiacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol 146:78PubMed Terris MK, Freiha FS, McNeal JE, Stamey TA (1991) Efficiacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol 146:78PubMed
16.
Zurück zum Zitat Norberg M, Egevad L,Holmberg L, Sparen P, Norlen B J, Busch C (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566CrossRefPubMed Norberg M, Egevad L,Holmberg L, Sparen P, Norlen B J, Busch C (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566CrossRefPubMed
17.
Zurück zum Zitat Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–75PubMed Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–75PubMed
18.
Zurück zum Zitat Bertermann H, Wirth B, Penkert A, Hansmann ML (1989) Ultraschallgezielte transrektale Prostatabiopsie: Bei 1 cm-Läsionen sicher im Ziel. Z Urol Poster 2:110–113 Bertermann H, Wirth B, Penkert A, Hansmann ML (1989) Ultraschallgezielte transrektale Prostatabiopsie: Bei 1 cm-Läsionen sicher im Ziel. Z Urol Poster 2:110–113
19.
Zurück zum Zitat Loch T, Bertermann H, Stöckle M (2000) Technische und anatomische Grundlagen des transrektalen Ultraschalls (TRUS) der Prostata. Urologe B 40:475–483CrossRef Loch T, Bertermann H, Stöckle M (2000) Technische und anatomische Grundlagen des transrektalen Ultraschalls (TRUS) der Prostata. Urologe B 40:475–483CrossRef
20.
Zurück zum Zitat Ravery V, Billebaud T, Toublanc M, Boccon-Gibod L, Hermieu JF, Moulinier F, Blanc E, Delmas V (1999) Diagnostic value of ten systematic TRUS-guided prostate biopsies. Eur Urol 35: 298–303CrossRefPubMed Ravery V, Billebaud T, Toublanc M, Boccon-Gibod L, Hermieu JF, Moulinier F, Blanc E, Delmas V (1999) Diagnostic value of ten systematic TRUS-guided prostate biopsies. Eur Urol 35: 298–303CrossRefPubMed
Metadaten
Titel
Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions
verfasst von
Tillmann Loch
Ursula Eppelmann
Jan Lehmann
Bernd Wullich
Annemie Loch
Michael Stöckle
Publikationsdatum
01.10.2004
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 5/2004
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-004-0462-4

Weitere Artikel der Ausgabe 5/2004

World Journal of Urology 5/2004 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.